US companies set the benchmark for Motif Bio - Graham Lumsden, chief executive of Motif Bio PLC 00:00:00

Share On Facebook Share On Twitter

Graham Lumsden, chief executive of Motif Bio PLC (LON:MTFB,NASDAQ:MTFB) caught up with Proactive as the company announced they'd secured US$20mln of non-dilutive financing to provide it with enough cash to see them through to the anticipated launch of its next-generation antibiotic in 2019.

Recent Videos